Stefanie Geisler

Stefanie Geisler, MD

Specializes In
  • Neurology
  • Adult Neurology
Languages Spoken
  • English
  • German


Sees Patients For

Peripheral neuropathy, myopathy/myositis, ALS-Lou Gehrig’s Disease, motor neuron disease

Hospital Affiliations

  • Barnes-Jewish Hospital



Board Certifications

  • Neurology and Psychiatry
  • Neuromuscular Medicine

Academic Title(s)

Assistant Professor, Neurology

Research Interests

Dr. Geisler’s laboratory research focuses on elucidating and understanding molecular mechanisms of axonal degeneration and regeneration in neuropathies. The translational goal is to find treatments to prevent axonal degeneration and facilitate regeneration.



2015 Neuromuscular Medicine, Washington University School of Medicine, St. Louis, Missouri


2013 Neurology, Washington University School of Medicine, St. Louis, Missouri

Postdoctoral Fellow

2006 Neuroscience, St. Louis University School of Medicine

Medical Degree

2003 Humboldt University, Berlin, Germany

Financial Disclosures
  • Sarepta Therapeutics
    • Royalties: $200,000 - $249,999
    • Reporting Date: 05/01/2022

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.